open access

Vol 48, No 1 (2017)
Prace poglądowe / Reviews
Published online: 2017-01-01
Submitted: 2016-06-28
Get Citation

Genetic alterations in B-acute lymphoblastic leukemia

Seyedeh Momeneh Mohammadi1, Daryosh Mohammad Nejad2, Hojjatollah Nozad Charoudeh1
DOI: 10.1016/j.achaem.2016.11.002
·
Acta Haematol Pol 2017;48(1):10-17.
Affiliations
  1. Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  2. Department of Anatomical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran

open access

Vol 48, No 1 (2017)
Prace poglądowe / Reviews
Published online: 2017-01-01
Submitted: 2016-06-28

Abstract

Considerable advances have been made in treatment of acute lymphoblastic leukemia (ALL) with an overall survival rate of 85% in children, and with a great improvement in adults. Despite this improvements and the accessibility of hematopoietic stem cell transplantation, relapsed ALL remains a leading cause of childhood mortality emphasizing the need of new approaches on therapy. Understanding of the pathobiology and genetic alteration of ALL has been enhanced by developing molecular technologies including microarray analysis and genome sequencing. These studies have helped identifying mutations in key signaling pathways and revolutionized the treatment of ALL by drugs which specifically target the genetic defects of leukemia cells, such as tyrosine kinase inhibitors. In this paper, we review the clinically important Genetic Alterations in ALL.

Abstract

Considerable advances have been made in treatment of acute lymphoblastic leukemia (ALL) with an overall survival rate of 85% in children, and with a great improvement in adults. Despite this improvements and the accessibility of hematopoietic stem cell transplantation, relapsed ALL remains a leading cause of childhood mortality emphasizing the need of new approaches on therapy. Understanding of the pathobiology and genetic alteration of ALL has been enhanced by developing molecular technologies including microarray analysis and genome sequencing. These studies have helped identifying mutations in key signaling pathways and revolutionized the treatment of ALL by drugs which specifically target the genetic defects of leukemia cells, such as tyrosine kinase inhibitors. In this paper, we review the clinically important Genetic Alterations in ALL.

Get Citation

Keywords

Genetic alterations; Leukemia; Signal transduction; Review

About this article
Title

Genetic alterations in B-acute lymphoblastic leukemia

Journal

Acta Haematologica Polonica

Issue

Vol 48, No 1 (2017)

Pages

10-17

Published online

2017-01-01

DOI

10.1016/j.achaem.2016.11.002

Bibliographic record

Acta Haematol Pol 2017;48(1):10-17.

Keywords

Genetic alterations
Leukemia
Signal transduction
Review

Authors

Seyedeh Momeneh Mohammadi
Daryosh Mohammad Nejad
Hojjatollah Nozad Charoudeh

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl